Modification to improve efficiency of sampling schedules for BA/BE testing of FDC anti-tuberculosis drugs.

Gabriels, G A; McIlleron, H; Smith, P J; Folb, P I; Fourie, P B

Gabriels, G A; McIlleron, H; Smith, P J; Folb, P I; Fourie, P B.

Affiliation

Gabriels GA; Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Rondebosch, South Africa. ggabriel@uctgsh1.uct.ac.za

Int J Tuberc Lung Dis ; 11(2): 181-8, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17263289

Subject(s)

Antitubercular Agents/pharmacokinetics; Blood Specimen Collection/methods; Antitubercular Agents/administration & dosage; Area Under Curve; Biological Availability; Ethambutol/administration & dosage; Ethambutol/pharmacokinetics; Humans; Isoniazid/administration & dosage; Isoniazid/pharmacokinetics; Pyrazinamide/administration & dosage; Pyrazinamide/pharmacokinetics; Quality Assurance, Health Care; Rifampin/administration & dosage; Rifampin/pharmacokinetics; South Africa; Therapeutic Equivalency

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 / 3_ND Database: MEDLINE Main subject: Blood Specimen Collection / Antitubercular Agents Type of study: Clinical_trials / Prognostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Int J Tuberc Lung Dis Year: 2007 Document type: Article

Search on Google

XML

PubMed Links